Originally derived from gastric proteins, BPC-157 works systemically to promote blood flow, tissue repair, and cellular regenerationmaking it highly valuable for patients dealing with injuries, chronic inflammation, gastrointestinal dysfunction, or delayed recovery
methylphenidate), which increase synaptic dopamine by directly blocking dopamine transporter (DAT)
It is not intended to treat any condition by itself
This is a mechanistically appealing strategy with strong preclinical support
KLOW, targeting joint and soft-tissue recovery models, benefits from KPV's anti-inflammatory input at the synovial and connective-tissue level
Sufficient for about 150 applications